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tain the level of collaboration between
their departments and local hospitals
in regard to WMD preparedness and a
coordinated medical and public health
response.  Forty-four (90%) of 49
CHDs completed the interview. One
of the 49 responding CHDs is respon-
sible for a six-county area, thus
accounting for the state’s 55 counties.
Fewer than half (20 of 44) of the
respondents have provided contact
information to local hospitals, and
barely 20% have reciprocal informa-
tion. Twenty-one percent were either
unaware of a policy for WMD pre-
paredness or reported that it was being
handled by another agency. Although
72% of CHDs had attended WMD
training, only 14% of the training was
in conjunction with hospitals. While
nearly two thirds rated their communi-
cation with hospitals as moderate to
strong, a similar proportion stated they
had no protocol for communicating
with hospitals about a WMD event.
Eighty-six percent of CHDs reported
that no new collaborative efforts were
directed towards the early identifica-
tion of new or emerging infectious
diseases possibly related to bioterror-
ism. However, approximately one
third of the CHDs thought they should
take initiative in this matter. Over 60%
indicated that primary responsibility
for identifying biological agents rested
in another agency or was not the sole
responsibility of the CHD. Further,
20% indicated they were weak or
untrained in this area and thought that
development and implementation of
policies, procedures, and training were
needed. While 93% of CHDs felt joint
training with hospitals would be bene-
ficial, particularly in defining their
respective roles in a WMD scenario,
many cited manpower and scheduling
constraints for such joint training ses-
sions. Overall, CHDs reported weak
relationships with area hospitals, but
thought that development or improve-
ment of policies and procedures
through regular meetings and training
would help prepare and plan for a
WMD event. 
The results of this survey suggest
that before September 11, West Vir-
ginia CHDs and local hospitals had lit-
tle collaboration in preparing to
respond to a WMD event. Despite the
recent terrorist activities, local health
departments and hospitals may still be
reluctant to spend resources in prepa-
ration for events with a low probabil-
ity of occurring, such as WMD
incidents. The local health depart-
ments and hospitals think that other
pressing programs will be jeopardized
(6–8). Many federal and state initia-
tives are under way to enhance the
public health infrastructure and its
preparation and response to bioterror-
ism. Improving on programs to meet
daily operational challenges, as well
as those presented by a WMD event,
must include the expertise of local
health departments and hospitals and
encourage the creation of innovative,
cost-effective preparedness programs
at the local level (9,10).  Future
research should be conducted in areas
of resource education and training,
allocation and sharing, personnel, and
policy. This research will indicate if
existing programs should be improved
and if new programs should be insti-
tuted.  
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In “Phylogenetic Analysis of a Human Isolate from the 2000
Israel West Nile virus Epidemic” by Thomas Briese et al., errors
occurred in the text and figure legend. On page 529, right column,
line 25, and in the figure legend on page 530, the host species for
ISR-00PigC is pigeon. Additionally, in the figure legend, the
GenBank accession no. for ISR-00PigC is AF380671, and the
GenBank accession no. for WNV-ROM96(0334)-1996 is
AF205879.
The online article at http://www.cdc.gov/ncidod/EID/
vol8no5/01-0324.htm has been corrected.
We regret any confusion these errors may have caused.
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